Benchmark upgraded shares of Cross Country Healthcare (NASDAQ:CCRN – Free Report) from a hold rating to a buy rating in a report issued on Thursday morning, MarketBeat.com reports. They currently have $14.00 target price on the business services provider’s stock.
CCRN has been the subject of several other research reports. Zacks Research raised shares of Cross Country Healthcare from a “strong sell” rating to a “hold” rating in a research note on Monday, January 19th. Jefferies Financial Group set a $8.65 price objective on shares of Cross Country Healthcare and gave the stock a “hold” rating in a report on Thursday, December 4th. Wedbush assumed coverage on shares of Cross Country Healthcare in a report on Tuesday, February 3rd. They issued a “neutral” rating and a $11.00 target price for the company. UBS Group decreased their price target on Cross Country Healthcare from $16.50 to $9.00 and set a “neutral” rating on the stock in a research note on Tuesday, December 9th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Cross Country Healthcare in a research report on Monday, December 29th. Three research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $12.03.
View Our Latest Analysis on Cross Country Healthcare
Cross Country Healthcare Trading Down 0.8%
Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) last posted its earnings results on Wednesday, March 4th. The business services provider reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.09). The business had revenue of $236.76 million during the quarter, compared to analysts’ expectations of $254.30 million. Cross Country Healthcare had a negative net margin of 9.00% and a positive return on equity of 0.12%. Cross Country Healthcare has set its Q1 2026 guidance at -0.060–0.040 EPS. On average, equities analysts expect that Cross Country Healthcare will post 0.53 EPS for the current fiscal year.
Hedge Funds Weigh In On Cross Country Healthcare
Several institutional investors have recently modified their holdings of CCRN. BNP Paribas Financial Markets increased its position in shares of Cross Country Healthcare by 50.0% during the second quarter. BNP Paribas Financial Markets now owns 3,424 shares of the business services provider’s stock worth $45,000 after acquiring an additional 1,142 shares during the period. Caitong International Asset Management Co. Ltd purchased a new position in Cross Country Healthcare in the fourth quarter valued at $46,000. Tower Research Capital LLC TRC grew its stake in Cross Country Healthcare by 422.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,586 shares of the business services provider’s stock worth $47,000 after purchasing an additional 2,899 shares in the last quarter. Graham Capital Management L.P. purchased a new stake in Cross Country Healthcare during the 4th quarter worth about $83,000. Finally, AXQ Capital LP purchased a new stake in Cross Country Healthcare during the 4th quarter worth about $109,000. Institutional investors and hedge funds own 96.03% of the company’s stock.
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.
The company’s core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.
Featured Articles
- Five stocks we like better than Cross Country Healthcare
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 15th, 2026
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- Your name isn’t on our protected list yet
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
